The Sleep Disorders Channel is supported through educational grants from Alkermes and Takeda.
VJNeurology is an independent medical education platform. Channel supporters have no influence over the production of content.
EAN 2026 | Ongoing research into foslevodopa/foscarbidopa in PD treatment
K. Ray Chaudhuri, MD, DSc, FRCP, FEAN, King’s College London, London, United Kingdom, discusses ongoing research into foslevodopa/foscarbidopa in the treatment of Parkinson’s disease (PD). Prof. Chaudhuri highlights the need for further research in diverse populations and a better understanding of how these agents impact sleep. This interview took place at the 12th Congress of the European Academy of Neurology (EAN) in Geneva, Switzerland.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
